sever
acut
respiratori
syndrom
sar
public
health
concern
worldwid
studi
human
leukocyt
antigen
hla
type
b
dr
dq
allel
chines
patient
serolog
confirm
sar
infect
identifi
strong
associ
hlab
ci
bonferronicorrect
p
p
p
valu
p
c
bonferroni
correct
p
p
p
develop
sar
moreov
frequenc
b
coinherit
ci
sar
group
significantli
higher
p
p
expect
gener
popul
genet
data
critic
affect
studi
pathogenesi
sar
design
vaccin
program
sever
acut
respiratori
syndrom
sar
public
health
concern
worldwid
studi
human
leukocyt
antigen
hla
type
b
dr
dq
allel
chines
patient
serolog
confirm
sar
infect
identifi
strong
associ
hlab
ci
bonferronicorrect
p
p
p
valu
p
c
bonferroni
correct
p
p
p
develop
sar
moreov
frequenc
b
coinherit
ci
sar
group
significantli
higher
p
p
expect
gener
popul
genet
data
critic
affect
studi
pathogenesi
sar
design
vaccin
program
sever
acut
respiratori
syndrom
sar
newli
describ
human
infecti
diseas
caus
novel
coronaviru
sarscov
sinc
first
appear
novemb
peopl
infect
multipl
outbreak
global
sar
infect
import
high
infect
unpredict
clinic
cours
character
high
mortal
rate
observ
clinic
sever
patient
may
vari
febril
condit
mild
respiratori
symptom
radiolog
evid
lung
involv
sever
respiratori
distress
extens
lung
damag
requir
assist
ventil
individu
suscept
infect
sarscov
also
appear
variabl
lymphopenia
absolut
lymphocyt
count
commonli
observ
onset
clinic
symptom
lymphocyt
seem
preferenti
destroy
b
cell
spare
although
evid
lung
involv
immunolog
natur
thu
far
known
effect
treatment
infect
autoimmun
pathogenesi
environment
genet
factorsespeci
hla
genotyp
influenc
abil
cell
respond
particular
antigen
viral
proteinclearli
import
strong
associ
infect
onset
autoimmun
suggest
infecti
agent
play
critic
role
process
patient
method
assess
associ
hla
genotyp
suscept
resist
sar
infect
diseas
sever
indic
admiss
intens
care
unit
icu
death
recruit
hla
genotyp
serolog
confirm
patient
fulfil
world
health
associ
case
definit
sar
manag
multipl
hospit
hong
kong
march
june
inform
consent
obtain
patient
guardian
accord
institut
guidelin
patient
sar
includ
studi
genet
unrel
chines
male
femal
ratio
age
rang
year
patient
studi
histori
admiss
icu
die
sar
episod
archiv
peripher
blood
pb
sampl
collect
edta
bottl
remain
routin
blood
test
use
inadequ
materi
obtain
sampl
hlaa
analysi
sampl
hlab
analysi
sampl
hladr
analysi
genom
dna
isol
patient
pb
sampl
standard
phenolchloroformisoamyl
alcohol
extract
ethanol
precipit
quantiti
qualiti
assess
spectroscop
absorb
nm
hla
class
class
ii
allel
genotyp
polymeras
chain
reaction
use
sequencespecif
primer
describ
elsewher
frequenc
hla
allel
found
patient
sar
compar
publish
frequenc
allel
popul
unrel
hong
kong
chines
bonemarrow
donor
class
iallel
group
class
iiallel
n
p
group
taken
hong
kong
marrow
match
n
p
registri
registri
compris
individu
age
rang
year
male
femal
ratio
slightli
ie
includ
slightli
women
men
true
overal
hong
kong
popul
b
hawkin
person
commun
hong
kong
locat
south
china
popul
chines
major
ancestr
origin
guangdong
provinc
southern
china
han
ethnic
group
term
age
sex
ethnic
group
patient
sar
stratif
similar
control
popul
thu
far
reliabl
represent
hong
kong
chines
although
previou
studi
type
hlaa
b
hong
kong
chines
bonemarrow
donor
perform
standard
serolog
techniqu
serolog
type
result
demonstr
high
concord
result
dna
type
regard
hlab
type
particular
discrep
serolog
dnabas
data
found
odd
ratio
respect
confid
interv
ci
calcul
contingencyt
analysi
determin
magnitud
associ
hla
allel
sar
infect
assess
signific
fisher
exact
test
use
compar
allel
frequenc
found
group
patient
sar
versu
allel
frequenc
control
group
p
consid
statist
signific
multipl
comparison
signific
level
p
c
adjust
divid
number
allel
detect
locu
accord
bonferroni
correct
result
discuss
result
fisher
exact
test
show
patient
sar
frequenc
hlab
significantli
higher
frequenc
significantli
lower
overal
hong
kong
chines
popul
tabl
bonferroni
correct
p
p
p
patient
sar
remain
statist
significantli
differ
overal
hong
kong
chines
popul
tabl
suggest
presenc
underli
genet
suscept
resistanceconf
hlab
polymorph
respectivelywith
regard
develop
sar
except
trend
toward
higher
frequenc
icuadmit
patient
sar
versu
nonicuadmit
patient
sar
correl
hla
genotyp
p
p
either
icu
admiss
death
relat
sar
previou
hla
studi
conduct
group
taiwanes
patient
probabl
infect
sar
suggest
frequenc
hlab
genotyp
significantli
higher
subgroup
patient
sever
sar
infect
group
highrisk
uninfect
healthcar
worker
studi
howev
observ
associ
hlab
sar
even
icuadmit
patient
sar
known
hlab
type
patient
sar
die
episod
frequenc
hlab
significantli
higher
overal
hong
kong
chines
popul
special
interest
strong
associ
patient
sar
hlab
patient
hlab
coinherit
alon
demonstr
excess
risk
sar
frequenc
b
coinherit
ci
patient
sar
significantli
higher
frequenc
expect
overal
hong
kong
chines
popul
possibl
b
confer
p
p
genet
suscept
infect
sar
wherea
may
play
secondari
role
pathogenesi
hand
data
support
idea
provid
protect
infect
sar
worthwhil
conduct
biolog
function
studi
involv
specif
hla
protein
found
present
studi
clarifi
particip
pathogenesi
sar
although
involv
hla
protein
pathogenesi
sar
remain
explor
understand
genet
risk
protect
confer
view
perspect
relat
control
viral
prolifer
persist
particip
autoimmun
pathogenesi
former
perspect
studi
hepat
c
viru
hcv
infect
human
papillomaviru
suggest
certain
hla
genotyp
influenc
host
abil
clear
viru
avoid
persist
evid
hcv
infect
provid
protect
effect
link
antiviraleffector
pathway
involv
helper
cell
geneticassoci
studi
strongli
suggest
class
ii
restrict
respons
may
import
immunolog
control
diseas
outcom
although
gene
implic
differ
studi
vari
ninetyeight
percent
patient
sar
develop
lymphopenia
characterist
mark
onset
symptom
decreas
cell
also
commonli
observ
found
present
associ
advers
outcom
contrast
rel
stabl
preserv
b
cell
postul
consist
earli
drop
count
observ
patient
sar
may
evid
impair
cell
respons
affect
sarscov
prolifer
patient
sar
altern
link
hla
loci
unknown
determin
govern
cours
infect
sar
subsequ
lung
damag
addit
implic
gene
close
link
gene
hla
class
ii
region
tnfa
may
also
play
import
role
gain
addit
insight
role
hla
polymorph
pali
suscept
resist
sar
perform
hla
test
famili
patient
sar
consid
genet
relat
unrel
famili
member
affect
unaffect
close
household
exposur
sar
index
patient
identif
individu
risk
infect
sar
may
help
select
prioriti
candid
vaccin
influenza
stage
futur
sar
vaccin
success
develop
may
help
select
candid
vaccin
sar
meanwhil
would
advis
healthcar
worker
harbor
hlasuscept
genotyp
consid
exempt
interact
patient
infect
sar
